139 related articles for article (PubMed ID: 31368675)
1. First-positive surveillance screening in an asymptomatic SDHA germline mutation carrier.
White G; Tufton N; Akker SA
Endocrinol Diabetes Metab Case Rep; 2019 May; 2019(1):. PubMed ID: 31368675
[TBL] [Abstract][Full Text] [Related]
2. Pathogenicity and Penetrance of Germline
Maniam P; Zhou K; Lonergan M; Berg JN; Goudie DR; Newey PJ
J Endocr Soc; 2018 Jul; 2(7):806-816. PubMed ID: 29978154
[TBL] [Abstract][Full Text] [Related]
3. Tumour detection and outcomes of surveillance screening in SDHB and SDHD pathogenic variant carriers.
White G; Velusamy A; Anandappa S; Masucci M; Breen LA; Joshi M; McGowan B; Hubbard JGH; Obholzer R; Christodoulou D; Jacques A; Touska P; Hassan FU; Izatt L; Carroll PV
Endocr Connect; 2022 Feb; 11(2):. PubMed ID: 35060925
[TBL] [Abstract][Full Text] [Related]
4. Potential Pitfalls of SDH Immunohistochemical Detection in Paragangliomas and Phaeochromocytomas Harbouring Germline
Santi R; Rapizzi E; Canu L; Ercolino T; Baroni G; Fucci R; Costa G; Mannelli M; Nesi G
Anticancer Res; 2017 Feb; 37(2):805-812. PubMed ID: 28179334
[TBL] [Abstract][Full Text] [Related]
5. A case of Carney triad complicated by renal cell carcinoma and a germline SDHA pathogenic variant.
Wurth R; Jha A; Kamilaris C; Gill AJ; Poplawski N; Xekouki P; Quezado MM; Pacak K; Stratakis CA; Hannah-Shmouni F
Endocrinol Diabetes Metab Case Rep; 2021 Mar; 2021():. PubMed ID: 33839693
[TBL] [Abstract][Full Text] [Related]
6. Succinate dehydrogenase (SDH)-deficient neoplasia.
Gill AJ
Histopathology; 2018 Jan; 72(1):106-116. PubMed ID: 29239034
[TBL] [Abstract][Full Text] [Related]
7. Molecular Alterations in Dog Pheochromocytomas and Paragangliomas.
Korpershoek E; Dieduksman DAER; Grinwis GCM; Day MJ; Reusch CE; Hilbe M; Fracassi F; Krol NMG; Uitterlinden AG; de Klein A; Eussen B; Stoop H; de Krijger RR; Galac S; Dinjens WNM
Cancers (Basel); 2019 Apr; 11(5):. PubMed ID: 31052272
[TBL] [Abstract][Full Text] [Related]
8. Bayesian approach to determining penetrance of pathogenic SDH variants.
Benn DE; Zhu Y; Andrews KA; Wilding M; Duncan EL; Dwight T; Tothill RW; Burgess J; Crook A; Gill AJ; Hicks RJ; Kim E; Luxford C; Marfan H; Richardson AL; Robinson B; Schlosberg A; Susman R; Tacon L; Trainer A; Tucker K; Maher ER; Field M; Clifton-Bligh RJ
J Med Genet; 2018 Nov; 55(11):729-734. PubMed ID: 30201732
[TBL] [Abstract][Full Text] [Related]
9. Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors.
Dwight T; Benn DE; Clarkson A; Vilain R; Lipton L; Robinson BG; Clifton-Bligh RJ; Gill AJ
Am J Surg Pathol; 2013 Feb; 37(2):226-33. PubMed ID: 23060355
[TBL] [Abstract][Full Text] [Related]
10. Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?
Tufton N; Sahdev A; Drake WM; Akker SA
Clin Endocrinol (Oxf); 2019 Jan; 90(1):31-46. PubMed ID: 30303539
[TBL] [Abstract][Full Text] [Related]
11. Genotype-phenotype associations in PPGLs in 59 patients with variants in SDHX genes.
Main AM; Rossing M; Borgwardt L; Grønkær Toft B; Rasmussen ÅK; Feldt-Rasmussen U
Endocr Connect; 2020 Aug; 9(8):793-803. PubMed ID: 32688340
[TBL] [Abstract][Full Text] [Related]
12. Succinate Dehydrogenase (SDH)-Deficient Pancreatic Neuroendocrine Tumor Expands the SDH-Related Tumor Spectrum.
Niemeijer ND; Papathomas TG; Korpershoek E; de Krijger RR; Oudijk L; Morreau H; Bayley JP; Hes FJ; Jansen JC; Dinjens WN; Corssmit EP
J Clin Endocrinol Metab; 2015 Oct; 100(10):E1386-93. PubMed ID: 26259135
[TBL] [Abstract][Full Text] [Related]
13. Genetic analysis of mitochondrial complex II subunits SDHD, SDHB and SDHC in paraganglioma and phaeochromocytoma susceptibility.
Astuti D; Hart-Holden N; Latif F; Lalloo F; Black GC; Lim C; Moran A; Grossman AB; Hodgson SV; Freemont A; Ramsden R; Eng C; Evans DG; Maher ER
Clin Endocrinol (Oxf); 2003 Dec; 59(6):728-33. PubMed ID: 14974914
[TBL] [Abstract][Full Text] [Related]
14. SDHB-Associated Paraganglioma Syndrome in Africa-A Need for Greater Genetic Testing.
Siddiqui N; Seedat F; Bulbulia S; Mtshali NZ; Botha A; Krause A; Daya R; Bayat Z
J Endocr Soc; 2021 Oct; 5(10):bvab111. PubMed ID: 34377882
[TBL] [Abstract][Full Text] [Related]
15. Identification of succinate dehydrogenase-deficient bladder paragangliomas.
Mason EF; Sadow PM; Wagner AJ; Remillard SP; Flood TA; Belanger EC; Hornick JL; Barletta JA
Am J Surg Pathol; 2013 Oct; 37(10):1612-8. PubMed ID: 23797725
[TBL] [Abstract][Full Text] [Related]
16. Succinate dehydrogenase (SDH) and mitochondrial driven neoplasia.
Gill AJ
Pathology; 2012 Jun; 44(4):285-92. PubMed ID: 22544211
[TBL] [Abstract][Full Text] [Related]
17. Mutational profile and genotype/phenotype correlation of non-familial pheochromocytoma and paraganglioma.
Albattal S; Alswailem M; Moria Y; Al-Hindi H; Dasouki M; Abouelhoda M; Alkhail HA; Alsuhaibani E; Alzahrani AS
Oncotarget; 2019 Oct; 10(57):5919-5931. PubMed ID: 31666924
[TBL] [Abstract][Full Text] [Related]
18. Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma/paraganglioma.
Dwight T; Mann K; Benn DE; Robinson BG; McKelvie P; Gill AJ; Winship I; Clifton-Bligh RJ
J Clin Endocrinol Metab; 2013 Jun; 98(6):E1103-8. PubMed ID: 23633203
[TBL] [Abstract][Full Text] [Related]
19. Germline genetic variants in pheochromocytoma/paraganglioma: single-center experience.
Lima JV; Scalissi NM; de Oliveira KC; Lindsey SC; Olivati C; Ferreira EN; Kater CE
Endocr Oncol; 2023 Jan; 3(1):e220091. PubMed ID: 37529773
[TBL] [Abstract][Full Text] [Related]
20. Succinate dehydrogenase variants in paraganglioma: why are B subunit variants 'bad'?
Gruber LM; Hart SN; Maher Iii LJ
Endocr Oncol; 2023 Jan; 3(1):e220093. PubMed ID: 37434649
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
